bromhexin km 8mg/ml perorální kapky, roztok
krewel meuselbach gmbh, eitorf array - 2075 bromhexin-hydrochlorid - perorální kapky, roztok - 8mg/ml - bromhexin
paxirasol 2mg/ml injekční roztok
egis pharmaceuticals plc, budapešť array - 2075 bromhexin-hydrochlorid - injekční roztok - 2mg/ml - bromhexin
lipertance 10mg/5mg/5mg potahovaná tableta
les laboratoires servier, suresnes cedex array - 16464 vÁpenatÁ sŮl atorvastatinu; 17238 perindopril-arginin; 12990 amlodipin-besilÁt - potahovaná tableta - 10mg/5mg/5mg - atorvastatin, amlodipin a perindopril
lipertance 20mg/10mg/10mg potahovaná tableta
les laboratoires servier, suresnes cedex array - 16464 vÁpenatÁ sŮl atorvastatinu; 17238 perindopril-arginin; 12990 amlodipin-besilÁt - potahovaná tableta - 20mg/10mg/10mg - atorvastatin, amlodipin a perindopril
lipertance 20mg/10mg/5mg potahovaná tableta
les laboratoires servier, suresnes cedex array - 16464 vÁpenatÁ sŮl atorvastatinu; 17238 perindopril-arginin; 12990 amlodipin-besilÁt - potahovaná tableta - 20mg/10mg/5mg - atorvastatin, amlodipin a perindopril
lipertance 20mg/5mg/5mg potahovaná tableta
les laboratoires servier, suresnes cedex array - 16464 vÁpenatÁ sŮl atorvastatinu; 17238 perindopril-arginin; 12990 amlodipin-besilÁt - potahovaná tableta - 20mg/5mg/5mg - atorvastatin, amlodipin a perindopril
lipertance 40mg/10mg/10mg potahovaná tableta
les laboratoires servier, suresnes cedex array - 16464 vÁpenatÁ sŮl atorvastatinu; 17238 perindopril-arginin; 12990 amlodipin-besilÁt - potahovaná tableta - 40mg/10mg/10mg - atorvastatin, amlodipin a perindopril
prenewel neo 10mg/2,5mg tableta
krka, d.d., novo mesto, novo mesto array - 17238 perindopril-arginin; 5513 indapamid - tableta - 10mg/2,5mg - perindopril a diuretika
momentum®
adama - ve vodě dispergovatelné granule - folpet + fosetyl-ai - fungicidy
icatibant accord
accord healthcare s.l.u. - icatibant acetate - angioedémy, dědičné - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.